SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-10-036538
Filing Date
2010-07-06
Accepted
2010-07-02 17:40:21
Documents
2
Period of Report
2010-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v189882_8ka.htm 8-K/A 31126
2 v189882_ex10-1.htm EX-10.1 406200
  Complete submission text file 0001144204-10-036538.txt   439083
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-53127 | Film No.: 10937100
SIC: 4731 Arrangement of Transportation of Freight & Cargo